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ABSTRACT 40 
A rare syndrome was first described in 1997 in a 17-year-old male patient presenting 41 
with Retinitis pigmentosa, HYpopituitarism, Nephronophthisis and Skeletal dysplasia 42 
(RHYNS). In the single reported familial case, two brothers were affected, arguing for 43 
X-linked or recessive mode of inheritance. Up to now, the underlying genetic basis of 44 
RHYNS syndrome still remains unknown. Here we applied whole-exome sequencing in 45 
the originally described family with RHYNS to identify compound heterozygous 46 
mutations in the ciliary gene TMEM67. Sanger sequencing confirmed a paternally 47 
inherited nonsense (p.Arg208*) and a maternally inherited missense mutation 48 
(p.Asp430Gly).  Overall, TMEM67 showed one of the widest clinical continuums 49 
observed in ciliopathies ranging from early lethality to adults with liver fibrosis.  50 
Our findings extended the spectrum of phenotypes/syndromes resulting from biallelic 51 
TMEM67 mutations to now eight distinguishable clinical conditions including RHYNS 52 
syndrome. 53 
 54 




RHYNS syndrome (OMIM 602152) was defined in 1997 by the acronym of Retinitis 58 
pigmentosa, HYpopituitarism, Nephronophthisis and mild Skeletal dysplasia in a 17-59 
year-old man1. A closely resembling phenotype with liver fibrosis has been previously 60 
described in a boy2, while Hedera and collaborators reported a similar condition in a 61 
family with two affected brothers3. The observation of affected males only and 62 
recurrence in a sib suggested either an X-linked or autosomal recessive inheritance 63 
pattern. Yet, the underlying genetic basis has remained unexplained, although the 64 
pattern of associated clinical features was compatible with a hereditary ciliary disorder. 65 
In this study, we reported the 20-year follow-up of the original patient with RHYNS 66 
syndrome. Whole-exome sequencing led to the identification of a compound 67 
heterozygous mutation in the gene TMEM67. The assignment of RYHNS syndrome as 68 
part of the wide spectrum of TMEM67-related ciliopathies is discussed.  69 
 70 
SUBJECTS AND METHODS 71 
Patient 72 
The index male patient was re-evaluated at the age of 38 years, still in search of a 73 
molecular diagnosis after receiving a clinical diagnosis of RHYNS syndrome at young 74 
age1. In brief, he was born with congenital palsy of the III and IV cranial nerve on the 75 
right resulting in complete ophthalmoplegia and upper eyelid ptosis and congenital 76 
palsy of the VI cranial nerve on the left with exotropia. At the age of 4 years, he 77 
measured 90 cm (-4,9SD) and showed delayed bone age. Growth hormone (GH) and 78 
thyreotropin releasing hormone (TSH) deficiency were diagnosed and treated with 79 
replacement therapy until young adulthood. At this age, radiological examination 80 
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showed mild signs of skeletal dysplasia consisting of osteopenia, thin tubular bones, 81 
epiphyseal hypoplasia and hypoplastic iliac bones with irregular acetabular margins. At 82 
age 11, retinitis pigmentosa and left sensorineural hearing loss were first diagnosed. 83 
Abnormal renal function was evident by age 12 years, when a renal biopsy 84 
demonstrated a histological pattern consistent with nephronophthisis. Due to the 85 
worsening of renal function he underwent a first kidney transplantation from a deceased 86 
donor at age 29; but it was rejected. Subsequently, he was started on hemodialysis and, 87 
at age 34, a second renal transplantation from deceased donor was performed. Since 88 
then, his clinical condition remained stable.  89 
We have evaluated the patient at age 38 years, when he measured 152 cm of height with 90 
weight 63,5 kg. Generalized and severe osteoporosis was diagnosed by DEXA 91 
examination (femoral head: T-Score -3.5, Z-Score -3.0, BMD 0,458 g/cm2; lumbar 92 
region: T-Score -3.1, Z-Score -3.0, BMD 0,752 g/cm2). A novel skeletal survey detected 93 
moderately shortened long bones, bowed radii, short femoral neck, brachydactyly at 94 
hands and feet with more severe involvement of middle phalanges, distal phalanx of the 95 
thumbs and metacarpals, moderately thickened calvarium, rotoscoliosis of mild degree, 96 
and a posterior arch defect of the sacrum. Diffuse reduction of the bone density with 97 
thinning of the diaphyseal cortex, was evident, particularly on hands (Figure 1).  98 
Hormonal dosage showed increased parathyroid hormone (PTH) levels in the blood 99 
(164 pg/ml, reference range 14-72 pg/ml), despite having received kidney 100 
transplantation. Beside this, all other hormonal levels (including thyroid, pituitary and 101 
steroid hormones) were repeatedly checked to be within the normal range. Of note, liver 102 
enzymes were repeatedly tested normal as was dedicated liver ultrasound. 103 
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Audiometry showed pantonal left-sided moderate-to-severe sensorineural hearing loss. 104 
Ophthalmologic examination confirmed no residual visual acuity and complete 105 
extinguishment of the electroretinogram in both eyes.  106 
Neuropsychological evaluation excluded functional deficits while brain imaging was 107 
normal. He obtained the chartered accountant qualification and he was completely self-108 
sufficient in all daily life activities, although he did not have an employment.  109 
 110 
Whole-Exome Sequencing 111 
In order to determine the genetic etiology of the RHYNS syndrome, WES was 112 
performed hypothesizing an-underlying autosomal recessive inheritance pattern. Exome 113 
capture and next-generation sequencing was carried out at Otogenetics Ltd. 114 
(http://www.otogenetics.com) on an Illumina HiSeq2000 (Illumina, San Diego, CA) 115 
platform and indexed libraries were subjected to paired-end (2×100 bp read length) 116 
sequencing-by-synthesis using fluorescent reversible terminators. Exome enrichment 117 
was conducted following the protocol for the SeqCap EZ Human Exome beads (Roche 118 
NimbleGen, Inc., Madison, WI, USA). Three µg DNAs, isolated from peripheral blood 119 
of the affected patient, his parents and two unaffected brothers were submitted for WES. 120 
Sequence reads were mapped to the human reference genome assembly (GRCh37/hg19) 121 
using CLC Genomics Workbench™ software (CLC bio, Aarhus, Denmark). Variants 122 
were called, filtered, and prioritized according to their pathogenicity scores obtained 123 
from the MutationTaster, CADD, and Polyphen-2 web interfaces. Furthermore, variants 124 
were cross-referenced with the Human Gene Mutation Database (HGMD, 125 
http://data.mch.mcgill.ca/phexdb), and genes known to be implicated in ciliopathy-126 




Two mutations in TMEM67 (NM_153704.5; MIM*609884) were identified in the 130 
proband, each inherited from a heterozygous parent, consistent with compound 131 
heterozygosity and autosomal recessive inheritance. The two identified mutations were 132 
confirmed by Sanger sequencing, namely, a nonsense mutation (c.622A>T, p.Arg208*) 133 
in exon 6 (paternal allele), and a missense mutation (c.1289A>G, p.Asp430Gly) near 134 
the splice acceptor site of exon 13 (maternal allele). The two healthy brothers were 135 
carriers of the nonsense mutation only (Figure 2). The missense variant was absent from 136 
the 1000 Genomes Project, the Exome Aggregation Consortium (ExAC, 137 
http://exac.broadinstitute.org) and the Genome Aggregation Database (gnomAD, 138 
http://gnomad.broadinstitute.org); conversely, the nonsense mutation was present at 139 
extremely low frequency in population databases (17 and 49 heterozygous individuals 140 
in ExAc and gnomAD, respectively). The nucleotide and deduced protein change were 141 
predicted as “disease causing” by the in silico pathogenicity prediction program 142 
MutationTaster (http://mutationtaster.org) which also predicted for the c.1289A>G a 143 
potential alteration of the acceptor splice site. In particular, using the Human Splicing 144 
Finder software (http://www.umd.be/HSF3/index.html) this mutation was predicted to 145 
abolish the canonical acceptor site with formation of a novel site leading to a shorter (-4 146 
bases) exon 13. The software also predicted the formation of an exonic splicing silencer 147 
and the alteration of exonic splicing enhancer.  148 
 149 
DISCUSSION  150 
In this study, we report the identification of biallelic mutations in the TMEM67 gene as 151 
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the underlying genetic defect causative of RHYNS syndrome. These findings extend the 152 
spectrum of phenotypes resulting from TMEM67 mutations to now eight distinguishable 153 
ciliopathies (Table 1). Their clinical manifestations display a wide range of 154 
presentations ranging from lethal phenotypes to patients with organ-specific 155 
involvement. Mutations in this gene were initially identified in Meckel syndrome, a 156 
lethal disorder displaying central nervous system (CNS) malformations, typically 157 
occipital encephalocele, multicystic kidneys, ductal plate dysplasia with congenital 158 
hepatic fibrosis (CHF) and postaxial polydactyly4. Subsequently, Baala and 159 
collaborators identified TMEM67 mutations in three patients with pure (isolated) 160 
Joubert syndrome (JS), thus defining the sixth JS locus (JBTS6)5. Indeed, different 161 
subtypes of JS were associated to TMEM67 mutations with distinct genotype-phenotype 162 
correlations within the spectrum of JS-related disorders (JSRDs), a group of pleiotropic 163 
ciliopathies which share in common the Molar Tooth Sign (MTS) at brain imaging6. In 164 
particular, the strongest correlation was defined with JS and CHF, since around 70% 165 
patients affected by so-called COACH syndrome (Cerebellar vermis hypo/aplasia, 166 
Oligophrenia, congenital Ataxia, ocular Coloboma, and Hepatic fibrosis) carried 167 
biallelic TMEM67 mutations7.  168 
In addition to Meckel syndrome and JSRDs, about 10% of patients affected by 169 
nephronophthisis (NPHP) and CHF without neurological involvement and normal brain 170 
imaging (NPHP11; MIM #613550) had TMEM67 mutations8. Interestingly, the same 171 
gene was also mutated in three children with a unique association of polycystic kidney 172 
(mimicking autosomal recessive polycystic kidney disease - ARPKD), NPHP, CHF and 173 
midbrain-hindbrain abnormalities within the MTS spectrum9. More recently, Tarailo-174 
Graovac et al.10 described a young adult patient with two mutations in TMEM67, who 175 
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displayed, in addition to the MTS and cerebellar atrophy at brain imaging, mild 176 
intellectual disability, adolescent-onset dementia, vertical gaze palsy, ataxia, and 177 
progressive hepatic fibrosis, overlapping Niemann-Pick type C manifestations. Lastly, 178 
TMEM67 was mutated in an otherwise healthy adult patient affected by isolated 179 
congenital hepatic fibrosis, which represented so far, the mildest end of the TMEM67-180 
related spectrum11. 181 
This intriguing clinical heterogeneity associated with mutations in one and the same 182 
gene calls for the delineation of specific genotype-phenotype correlations. The allelic 183 
spectrum of TMEM67 includes missense, truncating and splice site mutations, as well as 184 
rare multiexon deletions. Two truncating mutations (either frameshift, nonsense or 185 
splice site mutations) occur with high frequency in Meckel syndrome and are not 186 
reported in non-lethal phenotypes12. Conversely, two missense mutations or a 187 
combination of truncating /splicing and missense mutations are prevalent in less severe 188 
phenotypes within the JSRD spectrum, i.e. JS and COACH7. Hypomorphic mutations in 189 
TMEM67 are associated with NPHP and liver fibrosis (NPHP11), while more than half 190 
of these patients display ocular involvement8. Interestingly, our patient carried one 191 
truncating and one splicing mutation and his phenotype was mainly characterized by 192 
retinitis pigmentosa, NPH without any neurologic involvement or liver fibrosis. The 193 
absence of either neurologic or hepatic involvement is surprising since these are major 194 
manifestations of TMEM67 mutations (Table 1).  Altogether these observations 195 
emphasize the role of, yet unidentified, modifier factors in other genes modulating the 196 
penetrance of clinical manifestations. Of note, mutations at different loci interacting 197 
epistatically under a “multiallelic” inheritance has been proposed as a model for disease 198 
penetrance in ciliopathies such as Bardet-Biedl syndrome and nephronophthisis13,14.  199 
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In addition, our patient had hypopituitarism without structural abnormalities of the 200 
pituitary gland on brain MRI. Interestingly, growth hormone deficiency was not 201 
considered a major feature of JS, but recently two distinct genes (KIAA0753 and 202 
CELSR2) were associated with such endocrine anomalies in ciliopathies, strengthening 203 
the importance of ciliary function also in the development of the pituitary gland15,16. 204 
In conclusion, our data place RHYNS syndrome within the spectrum of TMEM67-205 
related ciliopathies. This is one of the widest clinical continuums resulting from 206 
recessive mutations in a single gene, ranging from early lethality to adults with liver 207 
fibrosis. More studies are encouraged to decipher modifier factors influencing the 208 
penetrance of clinical manifestations in ciliopathies.209 
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COACH: Cerebellar vermis hypo/aplasia, Oligophrenia, congenital Ataxia, ocular 214 
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GH: growth hormone 218 
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HGMD: Human Gene Mutation Database 220 
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JSRDs: Joubert syndrome related disorders 222 
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PTH: parathyroid hormone 225 
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Titles and legends to figures  317 
 318 
Figure 1: Radiological skeletal survey of the proband at age 38 years.  319 
 (a) Thickened calvarium. (b) Short and bowed radius. (c) Brachydactyly at hands with 320 
more severe involvement of middle phalanges, distal phalanx of the thumbs and 321 
metacarpals. Generalized reduction of bone density with thinning of the diaphyseal 322 
cortex is observed. (d) Rotoscoliosis. (e) Posterior arch defect of the sacrum and short 323 
femoral necks. 324 
 325 
Figure 2: Pedigree of the RHYNS family and TMEM67 electropherograms.  326 
(a) Family tree showing the proband (filled square symbol) and two healthy sibs. 327 
Circles and squares indicate females and males, respectively. (b) Genomic sequence 328 
electropherograms demonstrate a nonsense mutation (c.622A>T, p.Arg208*) in the 329 
father (I-1) and all 3 sons (II-1, II-2, II-3) and a missense mutation (c.1289A>G, 330 
p.Asp430Gly) in the affected son (II-1) and his mother (I-2). Arrows indicate a 331 
compound heterozygous mutation in the affected son and heterozygous changes in all 332 
other individuals. 333 
 334 
Legend to table: 335 
Table 1: TMEM67-related phenotypes and distinctive clinical manifestations. 336 
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Table 1. TMEM67-related phenotypes and distinctive clinical manifestations. 
 
Syndrome Major clinical features 




• Occipital encephalocele  
• Cystic dysplastic kidneys  
• Ductal plate malformation  
• Hepatic fibrosis  
• Postaxial polydactyly  
49 
Smith et al.4 
Khaddour et al.17 
Joubert syndrome 
• Molar tooth sign 
• Intellectual disability (variable)  
• Hypotonia  
• Irregular breathing pattern  
• Eye movement abnormalities  
30 
Baala et al.5 
Vilboux et al.6 
COACH 
• Molar tooth sign 
• Intellectual disability (variable)  
• Ataxia 
• Ocular coloboma 
• Hepatic fibrosis  
• Medullary cystic renal disease  
• Nephronophthisis  
31 
Brancati et al.7 
Doherty et al.18 
NPHP11 
• Nephronophthisis 
• Hepatic fibrosis 8 
Otto et al.8 
Srivastavaa et al.19 
ARPKD-like 
• Molar tooth sign-like  
• Speech apraxia 
• Polycystic kidneys 
• Nephronophthisis 
• Hepatic fibrosis 
3 Gunay-Aygun at al.9 
Niemann-Pick C 
phenocopy 
• Molar tooth sign  
• Cerebellar atrophy at young age 
• Intellectual disability  
• Gaze palsy 
• Ataxia 
• Adolescent-onset dementia 
• Hepatic fibrosis 
1 Tarailo-Graovac et al.10 
Isolated congenital 
liver fibrosis 
• Hepatic fibrosis in an otherwise 
healthy adult man 
1 Vogel et al.11 
RHYNS 
• Retinitis pigmentosa 
• Gaze palsy 
• GH- and TSH-deficiency 
• Nephronophthisis 
• Skeletal dysplasia 
• Sensorineural hearing loss 
 
1 This report 
 
Table legend: ARPDK: Autosomal Recessive Polycystic Kidney Disease; COACH: Cerebellar vermis 
hypo/aplasia, Oligophrenia, congenital Ataxia, ocular Coloboma, and Hepatic fibrosis; GH: growth 
hormone; NPHP: Nephronophthisis; RHYNS: Retinitis pigmentosa, HYpopituitarism, Nephronophthisis 
and Skeletal dysplasia; TSH: thyreotropin releasing hormone 
